1 not yet recruiting, 1 withdrawn. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Not yet recruiting 1, Withdrawn 1 |
Follow Spinocerebellar Ataxia Type 2: new trials by email Literature Review of Spinocerebellar Ataxia Type 2 trials Research Report on Spinocerebellar Ataxia Type 2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-SA) for Patients With Spinocerebellar Ataxia Intravenous infusion, Intrathecal injection, umbilical cord mesenchymal stem cell - Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 2 | Phase 2 | Not yet recruiting | Sclnow Biotechnology Co., Ltd. | 45 | 2026-12-31 | 2026-04-23 |
| Study of CAD-1883 for Spinocerebellar Ataxia CAD-1883, Placebos - Spinocerebellar Ataxias, Spinocerebellar Ataxia Type 1 | Phase 2 | Withdrawn | Cadent Therapeutics | 2021-06-01 | 2021-04-08 |
Machado-Joseph Disease (2) · Spinocerebellar Ataxias (2) · Ataxia (1) · Olivopontocerebellar Atrophy V (1) · Spinocerebellar Ataxia 10 (1) · Spinocerebellar ataxia 8 (1)
Brain Diseases (2) · Central Nervous System Diseases (2) · Cerebellar Ataxia (2) · Cerebellar Diseases (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Dyskinesias (2) · Genetic Diseases, Inborn (2) · Heredodegenerative Disorders, Nervous System (2) · Nervous System Diseases (2) · Neurodegenerative Diseases (2) · Neurologic Manifestations (2) · Spinal Cord Diseases (2) · Spinocerebellar Degenerations (2) · Ataxia (1) · Pathological Conditions, Signs and Symptoms (1)
Infusions, Intravenous (1) · Injections, Spinal (1)
Cadent Therapeutics (1) · Sclnow Biotechnology Co., Ltd. (1)
United States (1)
Hong Jiang (1)